Redx Pharma: Funding for IPF therapy development
19 Nov 2019
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
Redx Pharma Plc (REDX:LON) | 18.5 0 (-1.3%) | Mkt Cap: 72.0m
- Published:
19 Nov 2019 -
Author:
John Meyer | Sergey Raevskiy | Simon Beardsmore -
Pages:
3
Redx Pharma: Funding for IPF therapy development